Exo Unveils SweepAI™: A Smarter Era for Real-Time Ultrasound Scanning

Exo, a leader in accessible medical imaging, has introduced SweepAI™, a groundbreaking AI-powered ultrasound feature now FDA-cleared and integrated into the Exo Iris® platform. SweepAI™ offers real-time feedback during cardiac and lung scans, instantly identifying optimal imaging and delivering diagnostic insights without relying on internet connectivity. With this innovation, Exo has achieved FDA clearance for a total of nine AI-based indicators, revolutionizing the scanning process for conditions like congestive heart failure and stroke volume detection.

Beyond enhancing imaging precision, Exo has also launched Exo U, an on-device education platform that simplifies ultrasound learning. Described as “TikTok for POCUS,” Exo U delivers quick, interactive lessons within the app, allowing users to easily improve their scanning skills. Dr. Arun Nagdev, VP of Clinical at Exo, emphasized, “Learning now happens in real-time, with AI guiding you through every step.”

Exo’s latest updates don’t stop at AI innovation. The company continues to upgrade its Exo Iris device and Exo Works® platform with features like auto-color, auto-Doppler, and OB measurement packages. These advancements reaffirm Exo’s mission to push the boundaries of ultrasound technology, making it faster, smarter, and more accessible for healthcare providers worldwide.